Lidocaine Grindeks (Lidocaine Hydrochloride)

Lidocaine blocks voltage‑gated sodium channels on nerve membranes, stabilizing them in an inactive state. By preventing sodium influx, it stops the generation and propagation of action potentials, which interrupts nerve signal transmission and results in a temporary loss of sensation in the treated area.

The dose of lidocaine is individualized by the prescribing clinician based on the intended procedure, patient weight, age, comorbidities and the route of administration. Only a qualified healthcare professional should determine the appropriate amount and concentration for each case.

Safety data for lidocaine in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Clinicians should evaluate each situation carefully and follow local regulatory guidance.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Lidocaine Grindeks. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Lidocaine has a relatively rapid onset and moderate duration of action compared with alternatives such as bupivacaine, which lasts longer but has a slower onset. Lidocaine’s safety profile is well‑established, though it may be less potent for prolonged procedures, making it a common choice for short‑to‑moderate length interventions.

Lidocaine Grindeks should be stored at room temperature, below 25 °C, in its original packaging. Protect the solution from excessive light, moisture and extreme temperatures. Do not freeze. Inspect the container for any signs of contamination before use.

The product is supplied as a sterile solution for injection. It can be administered epidurally for spinal anesthesia, intravenously for regional blocks such as a Bier block, or subcutaneously for infiltration of a surgical site. Administration techniques follow standard aseptic procedures and are performed by qualified medical personnel.

The most critical adverse events include central nervous system toxicity (e.g., seizures), cardiovascular toxicity such as arrhythmias or cardiac conduction block, and severe allergic reactions including anaphylaxis. Prompt recognition and supportive management are essential if any of these events occur.

Lidocaine Grindeks is contraindicated in patients with a known hypersensitivity to lidocaine or other amide‑type local anesthetics, in those with severe heart block or uncontrolled arrhythmias, and in individuals with significant hepatic impairment where drug clearance is markedly reduced.